John P Finberg

This inventor holds 16 USPTO granted patents. Top assignees: Teva Pharmaceutical Industries Limited, Technion Research & Development Foundation Ltd. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John P Finberg. Retrieved from https://idiyas.com/inventor/john-p-finberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 6.3

ph-index = 16

Forward Citations = 613(Granted Patents)

Company Filing History:

16 out of 505

Teva Pharmaceutical Industries Limited

patents

14 out of 1,004

Technion Research & Development Foundation Ltd

patents

where one patent can have more than one assignee

Years Active: 1995-1999

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5994408 - Compositions containing and methods of using 1-aminoindan and (1999-11-30),

2. 5914349 - Compositions containing and methods of using 1-aminoindan and (1999-06-22),

3. 5891923 - R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia (1999-04-06),

4. 5880159 - Compositions containing and methods of using 1-aminoindan and (1999-03-09),

5. 5877221 - Compositions containing and methods of using 1-aminoindan and (1999-03-02),

6. 5786390 - Pharmaceutical compositions of the R-enantiomer of N-propargyl (1998-07-28),

7. 5744500 - Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions (1998-04-28),

8. 5668181 - Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the (1997-09-16),

9. 5599991 - Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan (1997-02-04),

10. 5576353 - Method of treating memory disorders using R-enantiomers of (1996-11-19),

11. 5532415 - R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses (1996-07-02),

12. 5519061 - R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses (1996-05-21),

13. 5486541 - Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as (1996-01-23),

14. 5457133 - R-enantiomers of N-propargyl-aminoindan compounds, their preparation and (1995-10-10),

15. 5453446 - Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for (1995-09-26),

Sure, I can help you with that. Here is an article about inventor John P Finberg:

Title: John P Finberg - A Trailblazer in the World of Inventions

Introduction:

John P Finberg, a passionate inventor with a relentless pursuit of innovation, has truly set himself apart as a trailblazer in the world of inventions. His commitment to creating solutions that make a difference has earned him recognition and respect in the industry. Hailing from Tivon, IL, John P Finberg has made significant contributions through his patented inventions.

Latest Patents:

John P Finberg holds an impressive total of 16 patents, with his latest innovations revolving around compositions containing and methods of using 1-aminoindan and novel derivatives of 1-aminoindan and their salts. These patents highlight his dedication to developing solutions for conditions such as Parkinson's disease, dementia, epilepsy, convulsions, and seizures.

Career Highlights:

Throughout his career, John P Finberg has made noteworthy contributions while working with renowned companies such as Teva Pharmaceutical Industries Limited and Technion Research & Development Foundation Limited. His innovative spirit and commitment to excellence have been instrumental in shaping the field of pharmaceutical research and development.

Collaborations:

Collaboration plays a key role in driving innovation, and John P Finberg has been fortunate to work alongside esteemed colleagues such as Ruth Levy and Moussa B Youdim. Together, they have shared expertise, exchanged ideas, and worked towards common goals, resulting in groundbreaking inventions and patents.

Conclusion:

In conclusion, John P Finberg's unwavering passion for innovation, coupled with his remarkable ingenuity, has cemented his position as a true pioneer in the world of inventions. His commitment to creating solutions that address significant medical conditions showcases his dedication to making a positive impact on society. With a track record of groundbreaking patents and collaborations with industry experts, John P Finberg continues to inspire and drive innovation in the field of pharmaceutical research and development.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]